Medical Laboratory Scientists Sample Clauses

Medical Laboratory Scientists. The employer may credit previous service for salary purposes only for connected service (as defined below) for medical laboratory technologists as follows: Service in private laboratories Full credit Service in hospital laboratories Full credit Service in university laboratories Full credit
Sample 1Sample 2Sample 3See All (18)
AutoNDA by SimpleDocs
Medical Laboratory Scientists. A Medical Laboratory Scientist shall receive an hourly wage rate approved by the employer for the position held. Step 27-Jun-16 26-Jun-17 Hourly Rate Annual Salary Hourly Rate Annual Salary Merit 7 41.401 86363 42.022 87658 Merit 6 39.905 83242 40.504 84491 Merit 5 38.659 80642 39.239 81852 Merit 4 37.411 78039 37.972 79210 Merit 3 36.164 75439 36.707 76571 Merit 2 34.917 72837 35.441 73930 Merit 1 33.670 70236 34.175 71290 MLS 8 32.423 67635 32.910 68650 MLS 7 31.363 65423 31.833 66404 MLS 6 30.303 63212 30.757 64160 MLS 5 29.243 61000 29.681 61915 MLS 4 28.183 58790 28.606 59672 MLS 3 26.936 56188 27.340 57031 MLS 2 25.939 54108 26.328 54920 MLS 1 24.941 52027 25.315 52807 MLS intern 22.447 46824 22.783 47526 Automatic Salary increments shall also take effect from the anniversary of the employee’s employment and employee(s) must have worked for a minimum of six months to qualify for any incremental increase.
Sample 1
Medical Laboratory Scientists. 5.6.1 Medical Laboratory Scientists Band/ Position Step 4-Aug-20 1-Nov-21 7-Mar-22 Advanced Clinician / Advanced Practitioner / Designated Positions 15 $105,246 $108,046 $110,946 M 14 $101,569 $104,369 $107,269 M 13 $97,892 $100,692 $103,592 M 12 $94,215 $97,015 $99,915 M 11 $90,536 $93,336 $96,236 M 10 $86,863 $89,663 $92,563 M 9 $83,183 $85,983 $88,883 M Additional Progression Step 8 $79,504 $82,304 $85,204 APS Graduate to Experienced Clinicians 7 $75,099 $77,899 $80,799 A 6 $71,090 $73,890 $76,790 A 5 $68,334 $71,134 $74,034 A 4 $65,050 $67,850 $70,750 A 3 $62,059 $64,859 $67,759 A 2 $59,690 $62,490 $65,390 A 1 $55,573 $58,373 $61,273 A Intern $50,140 $52,940 $55,840
Sample 1
Medical Laboratory Scientists. A Medical Laboratory Scientist shall receive an hourly wage rate approved by the employer for the position held. Scientist Scale Step 8/07/2019 Annual 6/07/2020 Annual 5/07/2021 Annual 4/07/2022 Annual Merit7 44.581 92,997 45.473 94,857 46.610 97,228 47.775 99,659 Merit6 42.971 89,637 43.830 91,430 44.926 93,716 46.049 96,059 Merit5 41.628 86,837 42.461 88,574 43.523 90,788 44.611 93,058 Merit4 40.285 84,034 41.091 85,715 42.118 87,858 43.171 90,054 Merit3 38.942 81,234 39.721 82,859 40.714 84,930 41.732 87,053 Merit2 37.599 78,432 38.351 80,001 39.310 82,001 40.293 84,051 Merit1 36.257 75,632 37.163 77,523 38.093 79,461 39.426 82,242 MLS8 34.914 72,831 36.032 75,485 37.185 77,567 38.374 80,049 MLS7 33.772 70,448 34.756 72,500 35.714 74,500 36.433 76,000 MLS6 32.631 68,068 33.283 69,429 33.949 70,818 34.628 72,234 MLS5 31.488 65,685 32.118 66,999 32.761 68,339 33.416 69,706 MLS4 30.348 63,306 30.955 64,572 31.574 65,863 32.205 67,180 MLS3 29.005 60,504 29.585 61,714 30.176 62,948 30.780 64,207 MLS2 27.931 58,265 28.490 59,430 29.060 60,619 29.641 61,831 MLS1 26.857 56,023 27.394 57,143 27.942 58,286 28.500 59,452 MLS Intern 24.171 50,421 24.654 51,429 25.148 52,458 25.651 53,507 Automatic Salary increments shall also take effect from the anniversary of the employee’s employment and employee(s) must have worked for a minimum of six months to qualify for any incremental increase.
Sample 1

Related to Medical Laboratory Scientists

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Technology Research Analyst Job# 1810 General Characteristics Maintains a strong understanding of the enterprise’s IT systems and architectures. Assists in the analysis of the requirements for the enterprise and applying emerging technologies to support long-term business objectives. Responsible for researching, collecting, and disseminating information on emerging technologies and key learnings throughout the enterprise. Researches and recommends changes to foundation architecture. Supports research projects to identify and evaluate emerging technologies. Interfaces with users and staff to evaluate possible implementation of the new technology in the enterprise, consistent with the goal of improving existing systems and technologies and in meeting the needs of the business. Analyzes and researches process of deployment and assists in this process.

  • Curriculum Vitae (a) The Chief Librarian shall maintain a curriculum vita for each Librarian. It is the Librarian’s responsibility to ensure that the curriculum vita on file is kept current. Members shall prepare their curriculum vita with the advice and assistance of their Chief Librarian. Members may revise their curriculum vita at any time.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Professional Development Program (a) The parties agree to continue a Professional Development Program for the maintenance and development of the faculty members' professional competence and effectiveness. It is agreed that maintenance of currency of subject knowledge, the improvement of performance of faculty duties, and the maintenance and improvement of professional competence, including instructional skills, are the primary professional development activities of faculty members.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Trials The Ship shall run the following test and trials:

Time is Money Join Law Insider Premium to draft better contracts faster.